These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 21646469)
1. Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Ghosh Z; Huang M; Hu S; Wilson KD; Dey D; Wu JC Cancer Res; 2011 Jul; 71(14):5030-9. PubMed ID: 21646469 [TBL] [Abstract][Full Text] [Related]
2. Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells. Li Z; Hu S; Ghosh Z; Han Z; Wu JC Stem Cells Dev; 2011 Oct; 20(10):1701-10. PubMed ID: 21235328 [TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic stability of human pluripotent stem cells. Lund RJ; Närvä E; Lahesmaa R Nat Rev Genet; 2012 Oct; 13(10):732-44. PubMed ID: 22965355 [TBL] [Abstract][Full Text] [Related]
4. miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Kim H; Lee G; Ganat Y; Papapetrou EP; Lipchina I; Socci ND; Sadelain M; Studer L Cell Stem Cell; 2011 Jun; 8(6):695-706. PubMed ID: 21624813 [TBL] [Abstract][Full Text] [Related]
5. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas. Kamada M; Mitsui Y; Matsuo T; Takahashi T Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines. Toivonen S; Ojala M; Hyysalo A; Ilmarinen T; Rajala K; Pekkanen-Mattila M; Äänismaa R; Lundin K; Palgi J; Weltner J; Trokovic R; Silvennoinen O; Skottman H; Narkilahti S; Aalto-Setälä K; Otonkoski T Stem Cells Transl Med; 2013 Feb; 2(2):83-93. PubMed ID: 23341440 [TBL] [Abstract][Full Text] [Related]
7. Markers of pluripotency and differentiation in human neural precursor cells derived from embryonic stem cells and CNS tissue. Sundberg M; Andersson PH; Åkesson E; Odeberg J; Holmberg L; Inzunza J; Falci S; Öhman J; Suuronen R; Skottman H; Lehtimäki K; Hovatta O; Narkilahti S; Sundström E Cell Transplant; 2011; 20(2):177-91. PubMed ID: 20875224 [TBL] [Abstract][Full Text] [Related]
8. Aquaporin expression and function in human pluripotent stem cell-derived retinal pigmented epithelial cells. Juuti-Uusitalo K; Delporte C; Grégoire F; Perret J; Huhtala H; Savolainen V; Nymark S; Hyttinen J; Uusitalo H; Willermain F; Skottman H Invest Ophthalmol Vis Sci; 2013 May; 54(5):3510-9. PubMed ID: 23687169 [TBL] [Abstract][Full Text] [Related]
9. Teratoma: from spontaneous tumors to the pluripotency/malignancy assay. Bulic-Jakus F; Katusic Bojanac A; Juric-Lekic G; Vlahovic M; Sincic N Wiley Interdiscip Rev Dev Biol; 2016; 5(2):186-209. PubMed ID: 26698368 [TBL] [Abstract][Full Text] [Related]
10. Hepatic differentiation of pluripotent stem cells. Loya K; Eggenschwiler R; Ko K; Sgodda M; André F; Bleidissel M; Schöler HR; Cantz T Biol Chem; 2009 Oct; 390(10):1047-55. PubMed ID: 19642877 [TBL] [Abstract][Full Text] [Related]
11. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells? Gunaratne PH Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978 [TBL] [Abstract][Full Text] [Related]
12. Intrinsic properties and external factors determine the differentiation bias of human embryonic stem cell lines. Mehta A; Mathew S; Viswanathan C; Sen Majumdar A Cell Biol Int; 2010 Oct; 34(10):1021-31. PubMed ID: 20586725 [TBL] [Abstract][Full Text] [Related]
14. Enrichment and purging of human embryonic stem cells by detection of cell surface antigens using the monoclonal antibodies TG30 and GCTM-2. Polanco JC; Wang B; Zhou Q; Chy H; O'Brien C; Laslett AL J Vis Exp; 2013 Dec; (82):50856. PubMed ID: 24335647 [TBL] [Abstract][Full Text] [Related]
15. Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen. Jones MB; Chu CH; Pendleton JC; Betenbaugh MJ; Shiloach J; Baljinnyam B; Rubin JS; Shamblott MJ Stem Cells Dev; 2010 Dec; 19(12):1923-35. PubMed ID: 20367282 [TBL] [Abstract][Full Text] [Related]
16. Clinical potentials of human pluripotent stem cells. Mora C; Serzanti M; Consiglio A; Memo M; Dell'Era P Cell Biol Toxicol; 2017 Aug; 33(4):351-360. PubMed ID: 28176010 [TBL] [Abstract][Full Text] [Related]
17. Induction of early neural precursors and derivation of tripotent neural stem cells from human pluripotent stem cells under xeno-free conditions. Nguyen HX; Nekanti U; Haus DL; Funes G; Moreno D; Kamei N; Cummings BJ; Anderson AJ J Comp Neurol; 2014 Aug; 522(12):2767-83. PubMed ID: 24715528 [TBL] [Abstract][Full Text] [Related]
18. A new route to human embryonic stem cells. Trounson A; Daley GQ; Pasque V; Plath K Nat Med; 2013 Jul; 19(7):820-1. PubMed ID: 23836223 [No Abstract] [Full Text] [Related]
19. Mouse embryonic stem cells irradiated with γ-rays differentiate into cardiomyocytes but with altered contractile properties. Rebuzzini P; Fassina L; Mulas F; Bellazzi R; Redi CA; Di Liberto R; Magenes G; Adjaye J; Zuccotti M; Garagna S Mutat Res; 2013 Aug; 756(1-2):37-45. PubMed ID: 23792212 [TBL] [Abstract][Full Text] [Related]
20. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Lee YK; Ng KM; Lai WH; Chan YC; Lau YM; Lian Q; Tse HF; Siu CW Stem Cell Rev Rep; 2011 Nov; 7(4):976-86. PubMed ID: 21614516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]